These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21482317)

  • 1. Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation.
    Snydman DR; Limaye AP; Potena L; Zamora MR
    Transplant Proc; 2011 Apr; 43(3 Suppl):S1-S17. PubMed ID: 21482317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
    Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for managing cytomegalovirus in transplant recipients.
    Razonable RR
    Expert Opin Pharmacother; 2010 Aug; 11(12):1983-97. PubMed ID: 20642369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update.
    Potena L; Solidoro P; Patrucco F; Borgese L
    Expert Opin Pharmacother; 2016 Aug; 17(12):1611-22. PubMed ID: 27340928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the effects of CMV on long-term transplant outcome.
    Baron C; Forconi C; Lebranchu Y
    Curr Opin Organ Transplant; 2010 Aug; 15(4):492-8. PubMed ID: 20631617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA
    Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.
    Kotton CN; Kumar D; Caliendo AM; Asberg A; Chou S; Snydman DR; Allen U; Humar A;
    Transplantation; 2010 Apr; 89(7):779-95. PubMed ID: 20224515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in invasive disease due to Candida species following heart and lung transplantation.
    Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
    Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late primary cytomegalovirus infection presenting with acute inflammatory demyelinating polyneuropathy in a heart transplant recipient: a case report and review of the literature.
    Hodowanec AC; Simon DM
    Transpl Infect Dis; 2012 Oct; 14(5):E116-20. PubMed ID: 22938143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytomegalovirus infection after heart transplantation. Retrospective analysis of an antiviral CMV prevention].
    Antretter H; Höfer D; Klaus A; Larcher C; Margreiter J; Margreiter R
    Dtsch Med Wochenschr; 2000 Apr; 125(15):445-51. PubMed ID: 10800441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP
    Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients.
    Kaplan CS; Petersen EA; Icenogle TB; Copeland JG; Villar HV; Sampliner R; Minnich L; Ray CG
    Arch Intern Med; 1989 Sep; 149(9):2095-100. PubMed ID: 2549896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
    Legendre C; Pascual M
    Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent cytomegalovirus disease in solid-organ transplant recipients.
    Falagas ME; Snydman DR
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):34-7. PubMed ID: 7482815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease.
    Humar A; Kumar D; Boivin G; Caliendo AM
    J Infect Dis; 2002 Sep; 186(6):829-33. PubMed ID: 12198618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual presentation of cytomegalovirus infection in patients after organ transplant.
    Tiple A; Kamar N; Esposito L; Mengelle C; Combelles S; Otal P; Celine Guilbeau-Frugier C; Rostaing L
    Exp Clin Transplant; 2009 Mar; 7(1):45-9. PubMed ID: 19364312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.
    Puchhammer-Stöckl E; Görzer I; Zoufaly A; Jaksch P; Bauer CC; Klepetko W; Popow-Kraupp T
    Transplantation; 2006 Jan; 81(2):187-94. PubMed ID: 16436961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
    Pollard RB
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S97-102. PubMed ID: 2456512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report.
    Icenogle TB; Peterson E; Ray G; Minnich L; Copeland JG
    J Heart Transplant; 1987; 6(4):199-203. PubMed ID: 2822880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.